Top Markets
#1 Black Phoenix Black Phoenix +823.46%
#2 Not in Employment, Education, or Training Not in Employment, Education, or Training +25.62%
#3 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +25.43%
#4 Beam Beam +24.43%
#5 Tutorial Tutorial +24.41%
#6 Bless Bless +19.73%
#7 SAFEcoin SAFEcoin +18.55%
#8 Magma Finance Magma Finance +17.14%
#9 MiL.k Alliance MiL.k Alliance +16.48%
#10 THORChain THORChain +16.18%
Coin of the day
Black Phoenix Black Phoenix
Paramètres
Langue
FRANçAIS
Devise
USD
Thème
BGI Genomics Co., Ltd. BGI Genomics Co., Ltd.

BGI Genomics Co., Ltd.

300676
Classement en actions #5740
BGI Genomics Co., Ltd. operates as an international supplier of genetic testing... BGI Genomics Co., Ltd. operates as an international supplier of genetic testing solutions and sequencing services. The company caters to a broad clientele, encompassing medical and research facilities, as well as other public and private organizations, both within China and across the globe. Its comprehensive service portfolio includes DNA, RNA, and tailored sequencing options. Additionally, it offers a suite of specialized genetic tests such as non-invasive prenatal testing (NIPT), reproductive health screening, and newborn genetic screening, alongside clinical exome sequencing. BGI Genomics also develops clinical and research-focused solutions for the field of oncology. During the COVID-19 pandemic, the firm provided crucial laboratory solutions for the detection and diagnosis of suspected cases, including SARS-CoV-2 IgM and IgG antibody detection kits, and real-time fluorescent RT-PCR kits. Their expertise spans numerous research domains, including but not limited to agriculture and food science, cancer research, metagenomics, reproductive health, biomarker discovery, and drug development. Established in 1999, the company initially operated under the name Shenzhen BGI Medicine Co., Ltd. before officially changing to BGI Genomics Co., Ltd. in 2015. Its corporate headquarters are located in Shenzhen, China.
Prix de l'action
$5.91
Capitalisation boursière
$2.47B
Changement (1 jour)
0.10%
Changement (1 an)
-22.57%
Pays
CN
Échange BGI Genomics Co., Ltd. (300676)

Catégorie

Healthcare
Bénéfices pour BGI Genomics Co., Ltd. (300676)
Bénéfices en 2026 TTM : 0
Selon les derniers rapports financiers de BGI Genomics Co., Ltd., les bénéfices actuels de l'entreprise sont de 0. En 2026, l'entreprise a réalisé un bénéfice de 0, égal à celui de 2026 qui était de 0. Les bénéfices affichés sur cette page correspondent aux bénéfices avant intérêts et impôts, appelés aussi EBIT.
Historique des bénéfices pour BGI Genomics Co., Ltd. de 2026 à 2026
Bénéfices à la fin de chaque année
Année Bénéfices Changez
Pas assez de données pour les dates fournies.
Bénéfices des entreprises similaires ou concurrentes
Entreprise Bénéfices Différence de bénéfices Pays
Thermo Fisher Scientific Inc. Thermo Fisher Scientific Inc.
Thermo Fisher Scientific Inc.
TMO.US
$7.61B -
US
Danaher Corporation Danaher Corporation
Danaher Corporation
DHR.US
$4.76B -
US
WuXi AppTec Co., Ltd. WuXi AppTec Co., Ltd.
WuXi AppTec Co., Ltd.
603259.SS
- -
CN
Natera, Inc. Natera, Inc.
Natera, Inc.
NTRA.US
$-252.70M -
US
Agilent Technologies, Inc. Agilent Technologies, Inc.
Agilent Technologies, Inc.
A.US
$1.58B -
US